Eiichi Tokutake
Kawaguchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
Journal: Clinical pharmacology and therapeutics
Published: September 28, 2023
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: October 31, 2022
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Journal: Cardiovascular drugs and therapy
Published: May 16, 2022
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
Journal: International journal of cardiology
Published: September 17, 2021
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Journal: Rheumatology (Oxford, England)
Published: July 14, 2021
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
Journal: European heart journal
Published: October 04, 2018
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
Journal: Journal of cardiology
Published: December 22, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026